420 related articles for article (PubMed ID: 16469501)
41. KML001 cytotoxic activity is associated with its binding to telomeric sequences and telomere erosion in prostate cancer cells.
Phatak P; Dai F; Butler M; Nandakumar MP; Gutierrez PL; Edelman MJ; Hendriks H; Burger AM
Clin Cancer Res; 2008 Jul; 14(14):4593-602. PubMed ID: 18628474
[TBL] [Abstract][Full Text] [Related]
42. Oligonucleotide inhibitors of telomerase: prospects for anticancer therapy and diagnostics.
Zvereva MI; Zatsepin TS; Azhibek DM; Shubernetskaya OS; Shpanchenko OV; Dontsova OA
Biochemistry (Mosc); 2015 Mar; 80(3):251-9. PubMed ID: 25761680
[TBL] [Abstract][Full Text] [Related]
43. Novel anticancer therapeutics targeting telomerase.
Ruden M; Puri N
Cancer Treat Rev; 2013 Aug; 39(5):444-56. PubMed ID: 22841437
[TBL] [Abstract][Full Text] [Related]
44. Discovery of new anti-cancer agents.
Lobbezoo MW; Krul MR; Pinedo HM
Forum (Genova); 1999; 9(3 Suppl 3):47-53. PubMed ID: 10607846
[TBL] [Abstract][Full Text] [Related]
45. Telomere inhibition and telomere disruption as processes for drug targeting.
Rezler EM; Bearss DJ; Hurley LH
Annu Rev Pharmacol Toxicol; 2003; 43():359-79. PubMed ID: 12540745
[TBL] [Abstract][Full Text] [Related]
46. Pharmacological telomerase inhibition can sensitize drug-resistant and drug-sensitive cells to chemotherapeutic treatment.
Ward RJ; Autexier C
Mol Pharmacol; 2005 Sep; 68(3):779-86. PubMed ID: 15939802
[TBL] [Abstract][Full Text] [Related]
47. Telomeres and telomerase in chronic myeloid leukaemia: impact for pathogenesis, disease progression and targeted therapy.
Keller G; Brassat U; Braig M; Heim D; Wege H; Brümmendorf TH
Hematol Oncol; 2009 Sep; 27(3):123-9. PubMed ID: 19569255
[TBL] [Abstract][Full Text] [Related]
48. Telomerase as an anti-cancer drug target: will it fulfil its early promise?
Newbold RF
Anticancer Drug Des; 1999 Aug; 14(4):349-54. PubMed ID: 10625927
[TBL] [Abstract][Full Text] [Related]
49. Roles of telomeres and telomerase in cancer, and advances in telomerase-targeted therapies.
Jafri MA; Ansari SA; Alqahtani MH; Shay JW
Genome Med; 2016 Jun; 8(1):69. PubMed ID: 27323951
[TBL] [Abstract][Full Text] [Related]
50. New prospects for targeting telomerase beyond the telomere.
Arndt GM; MacKenzie KL
Nat Rev Cancer; 2016 Aug; 16(8):508-24. PubMed ID: 27339602
[TBL] [Abstract][Full Text] [Related]
51. Are we close to the clinical development of novel drugs targeting telomeres and telomerase?
D'Incalci M; Zupi G
Eur J Cancer; 2005 May; 41(7):970. PubMed ID: 15862744
[No Abstract] [Full Text] [Related]
52. Specific telomere dysfunction induced by GRN163L increases radiation sensitivity in breast cancer cells.
Gomez-Millan J; Goldblatt EM; Gryaznov SM; Mendonca MS; Herbert BS
Int J Radiat Oncol Biol Phys; 2007 Mar; 67(3):897-905. PubMed ID: 17175117
[TBL] [Abstract][Full Text] [Related]
53. Fluorescence-based melting assays for studying quadruplex ligands.
De Cian A; Guittat L; Kaiser M; Saccà B; Amrane S; Bourdoncle A; Alberti P; Teulade-Fichou MP; Lacroix L; Mergny JL
Methods; 2007 Jun; 42(2):183-95. PubMed ID: 17472900
[TBL] [Abstract][Full Text] [Related]
54. Refining the telomere-telomerase hypothesis of aging and cancer.
Holt SE; Shay JW; Wright WE
Nat Biotechnol; 1996 Jul; 14(7):836-9. PubMed ID: 9631006
[TBL] [Abstract][Full Text] [Related]
55. [Regulation of telomerase and its clinical application in blood cells].
Yamada O
Rinsho Ketsueki; 2007 Feb; 48(2):117-33. PubMed ID: 17370640
[No Abstract] [Full Text] [Related]
56. How to inhibit telomerase activity for cancer therapy.
Kyo S; Inoue M
Curr Med Chem Anticancer Agents; 2002 Sep; 2(5):613-26. PubMed ID: 12678728
[TBL] [Abstract][Full Text] [Related]
57. Human telomerase expression regulation.
Gladych M; Wojtyla A; Rubis B
Biochem Cell Biol; 2011 Aug; 89(4):359-76. PubMed ID: 21790308
[TBL] [Abstract][Full Text] [Related]
58. Telomerase and the search for the end of cancer.
Mocellin S; Pooley KA; Nitti D
Trends Mol Med; 2013 Feb; 19(2):125-33. PubMed ID: 23253475
[TBL] [Abstract][Full Text] [Related]
59. [Telomerases: transformation trial!].
Lavelle F
Bull Cancer; 1999 Oct; 86(10):806-7. PubMed ID: 10610132
[No Abstract] [Full Text] [Related]
60. Telomeres, telomerase and oral cancer (Review).
Sebastian S; Grammatica L; Paradiso A
Int J Oncol; 2005 Dec; 27(6):1583-96. PubMed ID: 16273215
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
